Refreshing results…
TP53mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype
Download from ashpublications.orgOutcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms
UploadMissing publications? Search for publications with a matching author name.